These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1458692)

  • 1. Therapeutic intervention for hypercholesterolemia.
    Gotto AM
    Clin Cardiol; 1992 Nov; 15(11):III18-21; discussion III22-4. PubMed ID: 1458692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic intervention for hypercholesterolemia.
    Gotto AM
    Clin Cardiol; 1992 Nov; 15(11 Suppl 3):III18-21; discussion III22-4. PubMed ID: 1477993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cholesterol abnormalities.
    Lockman AR; Tribastone AD; Knight KV; Franko JP
    Am Fam Physician; 2005 Mar; 71(6):1137-42. PubMed ID: 15791891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional and pharmacologic approaches to hypercholesterolemia.
    Becker DM; Wilder LB
    Cardiovasc Nurs; 1987; 23(3):12-6. PubMed ID: 3649276
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical nutrition therapy lowers serum cholesterol and saves medication costs in men with hypercholesterolemia.
    Sikand G; Kashyap ML; Yang I
    J Am Diet Assoc; 1998 Aug; 98(8):889-94; quiz 895-6. PubMed ID: 9710659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When do we treat hypercholesterolemia?
    Brown WV
    Clin Cardiol; 1992 Nov; 15(11):III10-4; discussion III15-7. PubMed ID: 1458691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid management: tools for getting to the goal.
    McKenney JM
    Am J Manag Care; 2001 Aug; 7(9 Suppl):S299-306. PubMed ID: 11517816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When do we treat hypercholesterolemia?
    Brown WV
    Clin Cardiol; 1992 Nov; 15(11 Suppl 3):III10-4; discussion III 15-7. PubMed ID: 1477992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C; Olsson AG
    Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cholesterol-lowering regimens.
    Snyder S
    Am Fam Physician; 1990 Sep; 42(3):761-8. PubMed ID: 2168121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attaining United States and European guideline LDL-cholesterol levels with simvastatin in patients with coronary heart disease (the GOALLS study).
    Garmendia F; Brown AS; Reiber I; Adams PC
    Curr Med Res Opin; 2000; 16(3):208-19. PubMed ID: 11191012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial.
    Illingworth DR; Stein EA; Mitchel YB; Dujovne CA; Frost PH; Knopp RH; Tun P; Zupkis RV; Greguski RA
    Arch Intern Med; 1994 Jul; 154(14):1586-95. PubMed ID: 8031206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy and prevention of coronary heart diseases through lowering of the serum cholesterol levels; third consensus 'Cholesterol'. Consensus Working Group, CBO].
    Simoons ML; Casparie AF
    Ned Tijdschr Geneeskd; 1998 Sep; 142(38):2096-101. PubMed ID: 9856223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The heart of the matter. National guidelines urge more aggressive cholesterol treatment.
    Leake NB
    Adv Nurse Pract; 2002 Jan; 10(1):42-7; quiz 48-9. PubMed ID: 12420511
    [No Abstract]   [Full Text] [Related]  

  • 15. Low density lipoprotein cholesterol lowering: are the treatment guidelines still appropriate?
    Deslypere JP
    Int J Clin Pract; 2000 Jun; 54(5):307-13. PubMed ID: 10954957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NCEP's new guidelines at a glance. National Cholesterol Education Program.
    Benedict M
    Health Care Food Nutr Focus; 2002 Aug; 18(12):8-9. PubMed ID: 12192777
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic lifestyle changes and drug treatment for high blood cholesterol in China and application of the Adult Treatment Panel III guidelines.
    Muntner P; Gu D; Reynolds RF; Wu X; Chen J; Whelton PK; He J
    Am J Cardiol; 2005 Nov; 96(9):1260-5. PubMed ID: 16253594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination drug therapy for hypercholesterolemia. The trade-off between cost and simplicity.
    Heudebert GR; Van Ruiswyk J; Hiatt J; Schectman G
    Arch Intern Med; 1993 Aug; 153(15):1828-37. PubMed ID: 8333817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.